Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #3712 on GTC Biotherapeutics (fka GTCB)
DewDiligence
08/13/07 4:50 PM
#4598 RE: DewDiligence #3712
Executive Officers Geoffrey Cox, CEO 265K shares 722K options John Green, CFO 109K shares 307K options Harry Meade, SVP Research 107K shares 268K options Dan Woloshen, Gen. Counsel 81K shares 190K options Greg Liposky, SVP Oprtns 51K shares 246K options Dick Scotland, SVP Regltry 67K shares 129K options -- Six executive officers 680K shares 1,852K options
Independent directors Robert Baldridge 5K shares 75K options Kenneth Bauer 0 shares 38K options Christian Béchon 3K shares 15k options Francis Bullock 5K shares 74K options James Geraghty 70K shares 163K options Michael Landine 0 shares 38K options Pamela McNamara 6K shares 53K options Marvin Miller 5K shares 53K options Alan Tuck 11K shares 51K options -- Nine independent directors 105K shares 560K options
All officers/directors 785K shares 2,412K options